Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
2,643,944
-
Share change
-
-204,453
-
Total reported value
-
$3,621,000
-
Price per share
-
$1.40
-
Number of holders
-
9
-
Value change
-
-$280,205
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q4 2016
As of 31 Dec 2016 Aptose Biosciences Inc. - Common Shares had 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,643,944 shares of stock of the company.
Largest 9 holders included FRANKLIN RESOURCES INC, Cormorant Asset Management, LLC, BAKER BROS. ADVISORS LP, ROYAL BANK OF CANADA, TWO SIGMA SECURITIES, LLC, JANE STREET GROUP, LLC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, and UBS Group AG.
This table shows 9 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.